scMSI: Accurately inferring the sub-clonal Micro-Satellite status by an integrated deconvolution model on length spectrum
PLOS Computational Biology · 2024
DOI: 10.1371/journal.pcbi.1012608 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2024. Verfasst von Yuqian Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Algorithms, Bayes Theorem, Microsatellite Instability, Computational Biology. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Microsatellite instability (MSI) is an important genomic biomarker for cancer diagnosis and treatment, and sequencing-based approaches are often applied to identify MSI because of its fastness and efficiency. These approaches, however, may fail to identify MSI on one or more sub-clones for certain cancers with a high degree of heterogeneity, leading to erroneous diagnoses and unsuitable treatments. Besides, the computational cost of identifying sub-clonal MSI can be exponentially increased when multiple sub-clones with different length distributions share MSI status. Herein, this paper proposes “scMSI”, an accurate and efficient estimation of sub-clonal MSI to identify the microsatellite status. scMSI is an integrative Bayesian method to deconvolute the mixed-length distribution of sub-clones by a novel alternating iterative optimization procedure based on a subtle generative model. During the process of deconvolution, the optimized division of each sub-clone is attained by a heuristic algorithm, aligning with clone proportions that adhere optimally to the sample’s clonal structure. To evaluate the performance, 16 patients diagnosed with endometrial cancer, exhibiting positive responses to the treatment despite having negative MSI status based on sequencing-based approaches, were considered. Excitingly, scMSI reported MSI on sub-clones successfully, and the findings matched the conclusions on immunohistochemistry. In addition, testing results on a series of experiments with simulation datasets concerning a variety of impact factors demonstrated the effectiveness and superiority of scMSI in detecting MSI on sub-clones over existing approaches. scMSI provides a new way of detecting MSI for cancers with a high degree of heterogeneity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, China.
- Department of Pathology, State Key Laboratory of Complex Severe and Rare Disease, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical…
- Geneplus Beijing Institute, Beijing, China.
ORCID-Profile: Jiayin Wang
Förderung
- National Natural Science Foundation of China
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Liu, Y., Chen, Y., Wu, H., Zhang, X., Wang, Y., Yi, X., Liang, Z., & Wang, J. (2024). scMSI: Accurately inferring the sub-clonal Micro-Satellite status by an integrated deconvolution model on length spectrum. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012608
Vancouver
Liu Y, Chen Y, Wu H, Zhang X, Wang Y, Yi X, et al. scMSI: Accurately inferring the sub-clonal Micro-Satellite status by an integrated deconvolution model on length spectrum. PLOS Computational Biology. 2024. doi:10.1371/journal.pcbi.1012608
BibTeX
@article{Liu2024,
author = {Liu, Yuqian and Chen, Yan and Wu, Huanwen and Zhang, Xuanping and Wang, Yuqi and Yi, Xin and Liang, Zhiyong and Wang, Jiayin},
title = {scMSI: Accurately inferring the sub-clonal Micro-Satellite status by an integrated deconvolution model on length spectrum},
journal = {PLOS Computational Biology},
year = {2024},
doi = {10.1371/journal.pcbi.1012608}
}
EUVIMED